Revenue for Emcure Pharma Q2 rose by over 20%, totaling ₹2,002 Crore, driven by strong performance across segments.
Shares of Emcure Pharmaceuticals soared close to 6 percent higher, coming at a kissing distance to its record high of Rs ...
Shares of Emcure Pharma jumped 6 per cent at Rs 1523.80 a piece on the BSE after the company reported a strong second quarter ...
Revenue grew by 20.4% YoY to ₹2,002 crore, up from ₹1,663 crore in Q2 last fiscal. The company’s EBITDA rose 15.7% to ₹380.8 ...
Emcure Pharmaceuticals Ltd. announces the launch of a public awareness campaign on stroke prevention with cricket legend, MS Dhoni. Under this initiative, Emcure and Dhoni, through a video urge ...
Emcure Pharmaceuticals reports strong revenue growth driven by international and domestic businesses, with impressive EBITDA ...
Our Bureau, New Delhi Friday, November 8, 2024, 10:30 Hrs [IST] Pune-based Emcure Pharmaceuticals Ltd has posted growth of 38.2 per ...
Generic drugmakers Apotex and Heritage Pharmaceuticals have agreed to pay nearly $50 million to settle claims by Connecticut ...
2024 – Emcure Pharmaceuticals Limited (“Emcure”), a leading Indian Pharma company, is set to cater to a growing dermatology segment in India with formation of a wholly-owned subsidiary ...